Literature DB >> 57617

Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.

J G Levin, M J Rosenak.   

Abstract

Murine leukemia virus particles assembled in actinomycin D-treated cells were detected by determination of reverse transcriptase [RNA-dependent DNA polymerase (nucleotidyltransferase)] activity and by radioimmunoassay of the major virion protein, p30. The levels of enzyme activity and p30 protein were both 30-40% relative to the control over an 8 hr period, whereas after 3 or 4 hr infectivity was reduced by 95%. Thus, virions produced in the absence of RNA synthesis represent a fairly homogeneous population of defective particles. Although RNA synthesis is not necessary for virus assembly, protein synthesis is required. Treatment of cells with 10 mug/ml of cycloheximide reduced virus production by 80-85% within 2 hr, and by greater than 95% at later times. As might be expected from this finding, viral protein synthesis accompanies virus assembly in actinomycin D-treated cells. Newly synthesized proteins associated with the defective particles were identical with those found in standard virions and were present in the correct proportions. The results demonstrate that viral mRNA persists in cells in which RNA synthesis is blocked and continues to direct viral protein synthesis with a functional half-life of approximately 6-8 hr. Since viral mRNA is not packaged in virions even when viral RNA synthesis is shut off [Levin et al. (1974) J. Virol. 14, 152-161], we propose that murine leukemia virus-infected cells contain two nonequilibrating pools of intracellular viral RNA molecules, one associated with polyribosomes and one which is encapsidated into extracellular particles.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57617      PMCID: PMC430219          DOI: 10.1073/pnas.73.4.1154

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Dependence of Moloney murine leukemia virus production on cell growth.

Authors:  M P Paskind; R A Weinberg; D Baltimore
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences.

Authors:  G Jamjoom; W L Karshin; R B Naso; L J Arcement; R B Arlinghaus
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

3.  Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus.

Authors:  D Zaanie; A L Gielkens; M J Dekker-michielsen; H P Bloemers
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

4.  Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.

Authors:  J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

5.  Characterization of murine leukemia virus-specific proteins.

Authors:  E Fleissner; H Ikeda; J S Tung; E S Vitetta; E Tress; W Hardly; E Stockert; E A Boyse; T Pincus; P O'Donnell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

6.  POLYRIBOSOMES IN NORMAL AND POLIOVIRUS-INFECTED HELA CELLS AND THEIR RELATIONSHIP TO MESSENGER-RNA.

Authors:  S Penman; K Scherrer; Y Becker; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

7.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

8.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

9.  Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E).

Authors:  H Ikeda; W Hardy; E Tress; E Fleissner
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

10.  Breakdown of rat-liver ergosomes in vivo after actinomycin inhibition of messenger RNA synthesis.

Authors:  T STAEHELIN; F O WETTSTEIN; H NOLL
Journal:  Science       Date:  1963-04-12       Impact factor: 47.728

View more
  61 in total

1.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

Review 3.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 5.  Function of a retrotransposon nucleocapsid protein.

Authors:  Suzanne B Sandmeyer; Kristina A Clemens
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

6.  Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random.

Authors:  Jessica A Flynn; Alice Telesnitsky
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

7.  Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line.

Authors:  L R Boone; C L Innes; C K Heitman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours.

Authors:  S T Andreadis; D Brott; A O Fuller; B O Palsson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  Ty3 nucleocapsid controls localization of particle assembly.

Authors:  Liza S Z Larsen; Nadejda Beliakova-Bethell; Virginia Bilanchone; Min Zhang; Anne Lamsa; Rhonda Dasilva; G Wesley Hatfield; Kunio Nagashima; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.